Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexaria Bioscience Corp LEXX

Alternate Symbol(s):  LEXXW

Healthcare
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the... see more

Recent & Breaking News (NDAQ:LEXX)

Lexaria's Technology Now Works in Less Than 10 Minutes

Accesswire November 21, 2019

Lexaria's Technology Now Works in Less Than 10 Minutes

TheNewsWire November 21, 2019

Lexaria Announces Closing of Non-Brokered Private Placement

TheNewsWire November 14, 2019

Lexaria Awards Options

TheNewsWire November 5, 2019

Lexaria Bioscience Appoints Gregg Smith as Senior Advisor

Accesswire November 5, 2019

Lexaria Bioscience Appoints Gregg Smith as Senior Advisor Evolution VC Partners participates in equity financing

TheNewsWire November 5, 2019

Lexaria Equity Financing and Corporate Strategy Update

TheNewsWire October 30, 2019

Lexaria Applauds FDA Decision on Reduced Risk Tobacco Format

TheNewsWire October 24, 2019

Lexaria Bioscience Provides Update on R&D Program Progress under License Agreement with Altria

Accesswire October 8, 2019

Peer Reviewed Clinical Journal Publishes Lexaria Bioscience's Human CBD Study Results

Accesswire September 17, 2019

Peer Reviewed Clinical Journal Publishes Lexaria Bioscience's Human CBD Study Results

TheNewsWire September 17, 2019

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsAudio Publication Discussing Innovative Drug-Delivery Discovery

GlobeNewswire September 6, 2019

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsWire Publication Reporting on Momentous Advances in Drug-Delivery Innovation

GlobeNewswire September 5, 2019

Lexaria Bioscience Announces DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat Certain Disease Conditions

Accesswire August 27, 2019

Lexaria Bioscience Announces DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat Certain Disease Conditions

TheNewsWire August 27, 2019

Lexaria Announces Commercial Launch of ChrgD+ Odorless, Flavorless, Water-Soluble Powdered Hemp Oil

TheNewsWire August 21, 2019

More Companies Lining Up to Get Their Hands on Lexarias DehydraTECH Platform -- CFN Media

Newsfile August 15, 2019

Lexaria Bioscience Announces it has Received Four New Patents

Accesswire August 15, 2019

Lexaria's Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of Directors

Accesswire August 14, 2019

Lexaria Bioscience Receives Cannabis R&D License from Health Canada

Accesswire August 13, 2019